Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 18, 2010
SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit organization that promotes early detection and preventive intervention to reduce heart attack risk, says the just-released American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines is a great start, but more is needed to inform at-risk adults who have hidden heart attack risk..
In this video, Dr. Morteza Naghavi, executive chairman of the SHAPE II Task Force, speaks from the American Heart Association 2010 Scientific Sessions, explaining the organization's reaction to the new guideline.
After nearly a decade of work to encourage the widespread adoption of atherosclerosis tests for a subset of apparently healthy people who unknowingly have hidden heart disease (The SHAPE Guidelines published in the American Journal of Cardiology in 2006), we welcome these new practice guidelines and believe they represent a breakthrough. For the first time, the ACCF/AHA Task Force on Practice Guidelines has acknowledged the value of coronary artery calcium scoring (CACS) and carotid artery intima-media thickness (CIMT) scanning by ultrasound for cardiovascular risk assessment in subsets of asymptomatic subjects.
We hope these new practice guidelines will provide the peace-of-mind physicians need to encourage intermediate risk patients to undergo CACS or CIMT scanning. Of course, other obstacles to widespread testing remain, including insurance reimbursement for the tests. We expect the growing consensus of the efficacy of these atherosclerosis tests will significantly advance efforts to expand reimbursement so all patients who can benefit from the tests have access to them.
Our enthusiasm about this victory is tempered by the ACCF/AHA Task Force stopping short of an outright recommendation of the two atherosclerosis tests recommended by SHAPE. We believe the evidence is sufficient to recommend CACS or CIMT scanning for risk assessment of men 45-80 years of age and women 55-80 years of age who have a Framingham Risk Score of 6% or greater. By stating that a test "is reasonable," the ACCF/AHA Task Force has removed doubt about the tests, but the absence of a stronger Class 1 recommendation may create uncertainty. SHAPE believes that the tests should be recommended. The updated SHAPE II Guidelines provide a simple and sensible approach to implement these tests in clinical practice.
However, the new ACC/AHA Guidelines are a giant leap from the skepticism and outright opposition expressed in the past. Physicians who advise their asymptomatic intermediate risk patients to undergo the tests are no longer at odds with the major practice guidelines.
We applaud the ACCF/AHA Task Force for carefully examining the advances in research and practice that clearly illustrate the effectiveness of CACS and CIMT scanning for assessing an individual's cardiovascular risk. We will be forever grateful to the research teams and their sponsors who enabled this enormous advance in heart attack risk detection, including the Atherosclerosis Risk in Communities Study (ARIC) and the Multi-Ethnic Study of Atherosclerosis (MESA), sponsored by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health, and the Heinz Nixdorf Recall Study, funded by the Heinz Nixdorf Foundation and the German Foundation of Research.
Based in Houston, the Society for Heart Attack Prevention and Eradication (SHAPE) is a non-profit organization that promotes education and research related to prevention, detection and treatment of hidden heart attack risk. SHAPE is committed to raising public awareness about revolutionary discoveries that are opening exciting avenues to prevent heart attacks. SHAPE's mission is to eradicate heart attacks in the 21st century. Additional information is available on the organization's Web site at http://www.shapesociety.org.